Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Remimazolam Besylate in Sedation of Postcardioperative Patients — Stella

Home/Remimazolam/Remimazolam Besylate in Sedation of Postcardioperative Patients

View on ClinicalTrials.gov

Recruiting

Back to Remimazolam trials

Remimazolam Besylate in Sedation of Postcardioperative Patients

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

First afflilated hospital of zhejiang university school of medicine, Hangzhou, Zhejiang

Key details

Sponsor

First Affiliated Hospital of Zhejiang University

Enrollment target

~120 participants

Started

February 2025

Primary completion

April 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.